GRI Bio Inc. (GRI)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.72M
Last updated: Nov 17, 2026 at 11:04 AM ET
GRI Bio Inc. (GRI) Stock Forecast
Analysts expect GRI Bio (GRI) to earn -$3.90 per share in the fiscal year ending Dec 31, 2026. Over the last 30 days, 2 estimates for the fiscal year ending Dec 31, 2026 were revised up and 0 down. For the fiscal year ending Dec 31, 2027, the EPS consensus is -$2.00.
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus shows a smaller loss.
- Fiscal year ending Dec 31, 2026
- -$3.90
- EPS consensus
- Fiscal year ending Dec 31, 2027
- -$2.00
- EPS consensus
- Next report
- Feb 2, 2027
- Estimated
EPS range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$3.90 | -$4.13 to -$3.66 | 2 |
| Dec 31, 2027 | -$2.00 | -$3.79 to -$0.21 | 2 |
Quarterly Estimates
| Quarter ending | EPS consensus | EPS range | EPS analysts |
|---|---|---|---|
| Dec 31, 2026 | -$0.83 | -$0.89 to -$0.78 | 3 |
Estimate Revisions
Across the 2 periods below, the last 30 days brought 4 upward and 0 downward EPS revisions. Raises outnumber cuts in every period.
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Dec 31, 2026 | 2 | 0 |
| Fiscal year ending Dec 31, 2027 | 2 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has improved from -$4.77.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Dec 31, 2026 | -$3.90 | -$3.90 | -$3.90 | -$4.77 | -$4.77 | N/A |
| Fiscal year ending Dec 31, 2027 | -$2.00 | -$2.00 | -$2.00 | -$2.54 | -$2.54 | N/A |
Frequently Asked Questions About GRI
What is the GRI stock forecast?
Consensus analyst estimates put GRI Bio's EPS at -$3.90 for the fiscal year ending Dec 31, 2026.
What EPS do analysts expect from GRI next year?
For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is -$3.90, with estimates from -$4.13 to -$3.66 from 2 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is -$2.00, with estimates from -$3.79 to -$0.21 from 2 analysts.
How many analysts cover GRI?
2 analysts estimate EPS for GRI Bio for the fiscal year ending Dec 31, 2026.
GRI pages: Overview, Earnings, Forecast, Financials, Competitors